In response to the urgent need for improved drug safety in Indonesia, the Indonesian Food and Drug Authority (BPOM) enacted BPOM Regulation 10/2024 on June 7, 2024. This new law mandates strict labeling standards for natural medicines, quasi-medicines, and health supplements.

Dentons HPRP’s lawyers, Nashatra Prita (Partner) and Yasya Alifya Radiany (Associate) explore the critical aspects and implications of this regulation, highlighting certain essential types of information required on labels to ensure compliance to the new regulation. With a compliance deadline set for June 2026, both local and foreign business actors must meet these new standards to avoid severe sanctions. Discover the key steps for compliance and the impact on your business operations in their insightful analysis, essential for local distributors and foreign principals supplying to Indonesia.

Full article click here

For further information related to the services provided, please contact the Partner listed under key contact.